Shares of healthcare companies advanced after a U.S. proposal to waive patents for Covid-19 vaccines met with fierce opposition from European governments and pharmaceutical giants. Cansino Biologics rallied 8.5% to 480.50 yuan
Shares of Shanghai Fosun Pharmaceutical Group surged by the 10% daily limit to 60.12 yuan after the drugmaker a unit will form a venture with Germany-based BioNTech to build a plant in China capable of producing 1 billion doses of Covid-19 vaccines a year.
Energy shares CNOOC and PetroChina rose, as crude oil futures rose on concern about disruption of supplies after cyber attack shut down a U.S. pipeline operator that provides nearly half of the U.S. east coast's fuel supply.
Shares of tech companies declined after the internet watchdog on Saturday announced a ban on some mobile app notifications, as regulators ramp up a campaign to rein in internet firms' growing influence.
CURRENCY NEWS: China yuan appreciated to a 3-1/2-month high against the dollar on Monday, inline with softer mid-point fixing by central bank. Prior to market opening, the People's Bank of China (PBOC) lifted the midpoint rate CNY=PBOC by the most since early January to 6.4425 per dollar, 253 pips firmer than the previous fix of 6.4678. In the spot market, the onshore yuan CNY=CFXS opened at 6.4320 per dollar and rose to a high of 6.4265, the firmest since Jan. 29. By midday, it was changing hands at 6.4295, 13 pips firmer than the previous late session close.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
